To the Editor The recently published Original Investigation by Douketis and colleagues1 is commendable and helps advance the care and management of perioperative patients on a direct oral anticoagulant for treatment of atrial fibrillation. Further elaboration of study details and results will be of value for perioperative health care providers interpreting this work. From their data, the authors showed that 6% to 8% of patients received neuraxial anesthesia and 54% 55% of patients received other (eg, nongeneral, nonneuraxial) anesthesia for their procedures.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Pysyk CL. Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med. 2020;180(2):332. doi:10.1001/jamainternmed.2019.5861
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: